PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, China.\', \'Key Laboratory of Research on Quality and Standardization of Biotech Products, National Health Commission, Beijing, China.\', \'CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.\', \'Department of Veterinary, College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.\', \'Department of Arboviral Vaccine, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, China.\', \'Laboratory of Virology and Immunology, Translational Medicine Institute, the First People\'s Hospital of Chenzhou, University of South China, Chenzhou, China.\', \'Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/jmv.27596
?:doi
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 35032057
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all